Hans Grönlund's research group
Therapeutic Immune Design
We focus on diagnostics and curative treatments of chronic inflammatory diseases and cancer. Central to our research is the design and production of proteins for analyses of pathogenic antibodies and immune cells. The goal is to provide novel remedies applicable for clinical use. Therefore we adopt a translational research approach; we have established collaboration with clinicians, SciLife lab, biotechnical and medical companies, as well as academic research groups in Sweden and abroad. All our efforts aim to improve the quality of life for patients.
- Autoantigens in multiple sclerosis (MS)
- Allergenes as tools for diagnosis and treatment of allergic disease
- Cancer immunotherapy
Designing a multimer allergen for diagnosis and immunotherapy of dog allergic patients.
PLoS ONE 2014 ;9(10):e111041
Dog saliva - an important source of dog allergens.
Allergy 2013 ;68(5):585-92
Characterization of the dog lipocalin allergen Can f 6: the role in cross-reactivity with cat and horse.
Allergy 2012 Jun;67(6):751-7
Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.
Allergy 2008 May;63(5):518-26
The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family.
J. Biol. Chem. 2003 Sep;278(39):37730-5
The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).
Clin. Exp. Allergy 1999 Jul;29(7):896-904
|Mattias Bronge||Doktorand, Forskarstuderande|
|Jonas Bronge||Forskningsassistent (använd ej)|
|Hans Grönlund||Forskare, Forskargruppsledare|
|Anna Wintersand||Doktorand, Forskarstuderande|